In less than a decade, impossibility turned the corner into reality. Infusions of cash and technical support from international donors, as well as growing political will in some developing countries, have provided life-saving antiretroviral drugs to an estimated 5 million people living with HIV/AIDS in resource-poor regions. But now the global HIV/AIDS community must find a way to turn yet another corner by maintaining those 5 million patients on antiretrovirals and offering the drugs to millions more in the midst of a persistent global economic crisis.
Voelker R. One Casualty of Global Economic Crisis: Uncertain Finances for HIV/AIDS Programs. JAMA. 2010;304(3):259-261. doi:10.1001/jama.2010.962